HRI

Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Total revenue 861 M1 B1.3 B1.21 B1.14 B1.2 B 4.86 B Gross profit 501 M578 M767 M704 M613 M638 M 2.72 B Operating expenses 243 M316 M305 M349 M254 M264 M 1.17 B Selling/general/admin expenses 118 M127 M166 M153 M146 M155 M 620 M Research & development —————— — Operating income 258 M262 M462 M355 M359 M374 M 1.55 B Non-Operating Income, Total 30 M22 M17 M16 M32 M30 M 95 M Interest expense, net of interest capitalized 2 M2 M4 M3 M4 M4 M 15 M Non-Operating Income, excl. Interest Expenses 27 M18 M13 M22 M25 M20 M 80 M Unusual income/expense 1 M2 M0-9 M3 M6 M 0 Pretax income -8 M-46 M38 M17 M-23 M24 M 56 M Equity in earnings —————— — Taxes 10 M-11 M8 M-7 M1 M5 M 7 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations -18 M-35 M30 M24 M-24 M19 M 49 M Discontinued operations —————— — Net income -18 M-35 M30 M24 M-24 M19 M 49 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -18 M-35 M30 M24 M-24 M19 M 49 M Basic earnings per share (Basic EPS) -0.63-1.170.90.93-0.720.57 1.68 Diluted earnings per share (Diluted EPS) -0.63-1.170.90.93-0.720.57 1.68 Average basic shares outstanding 28.5 M30 M33.2 M31.3 M33.3 M33.4 M — Diluted shares outstanding 28.5 M30 M33.3 M31.4 M33.3 M33.5 M — EBITDA 296 M314 M540 M509 M440 M457 M 1.95 B EBIT 258 M262 M462 M355 M359 M374 M 1.55 B Cost of revenue 360 M424 M537 M505 M526 M566 M 2.13 B Other cost of goods sold 327 M379 M467 M429 M453 M491 M 1.84 B Depreciation & amortization (cash flow) 38 M52 M78 M154 M81 M83 M 396 M